文献速递糖尿病

补盐对盐敏感2型糖尿病患者交感神经活性及内皮功能的影响

Effect of Salt Supplementation on Sympathetic Activity and Endothelial Function in Salt-Sensitive Type 2 Diabetes.
PubMed 文献 · J Clin Endocrinol Metab · 2020-01-01

结果显示补盐增加肌肉交感神经活性(MSNA),但未改变内皮功能、动脉僵硬度、动态血压或心率变异性,同时改善压力反射敏感性并降低醛固酮。

要点

  • 补盐增加MSNA burst频率(P=.047)和burst发生率(P=.016)。
  • 补盐未显著改变RHI、AI、动态血压或HRV。
  • 补盐改善压力反射斜率(P=.026)并降低醛固酮(P=.004)。

核心结论

  • 在 habitual 低钠摄入的2型糖尿病患者中,补盐增加交感神经活性但不改变内皮功能或血压,并改善压力反射功能。
  • 盐抵抗个体补盐后内皮功能有改善趋势(RHI P=.07)。

研究设计与样本

  • 随机、双盲、安慰剂对照交叉试验。
  • 干预为补盐(100 mmol NaCl/24h)或安慰剂,各持续3周。

主要发现

  • 与安慰剂相比,补盐增加MSNA burst频率(P=.047)和burst发生率(P=.016)。
  • 补盐未显著影响RHI(P=.24)、AI(P=.201)、动态血压(收缩压P=.09,舒张压P=.14)和HRV。
  • 补盐改善压力反射斜率(P=.026)并降低醛固酮(P=.004)。
  • 盐抵抗个体补盐后RHI有改善趋势(P=.07)。

临床怎么用

  • 对 habitual 低钠摄入的2型糖尿病患者,补盐可能通过改善压力反射功能带来获益,但需注意交感神经活性增加。
  • 盐抵抗个体可能从补盐中获得内皮功能改善,但证据尚待进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Lower sodium intake is paradoxically associated with higher mortality in type 2 diabetes (T2D). OBJECTIVE: To determine whether sympathetic nervous system (SNS) activation and endothelial dysfunction contribute to these observations, we examined the effect of salt supplementation on these systems in people with T2D with habitual low sodium. We hypothesized that salt supplementation would lower SNS activity and improve endothelial function compared to placebo. DESIGN: We conducted a randomized, double-blinded, placebo-controlled crossover trial. SETTING: The study took place in a tertiary referral diabetes outpatient clinic. PARTICIPANTS: Twenty-two people with T2D with habitual low sodium intake (24-hour urine sodium <150 mmol/24h) were included. INTERVENTION: Salt supplementation (100 mmol NaCl/24h) or placebo for 3 weeks was administered. MAIN OUTCOME MEASURES: The primary outcome of SNS activity and endothelial function was assessed as follows: Microneurography assessed muscle sympathetic nerve activity (MSNA), pulse amplitude tonometry assessed endothelial function via reactive hyperemic index (RHI), and arterial stiffness was assessed via augmentation index (AI). Secondary outcomes included cardiac baroreflex, serum aldosterone, ambulatory blood pressure monitoring (ABPM), heart rate variability (HRV), and salt sensitivity. RESULTS: Compared to placebo, salt supplementation increased MSNA (burst frequency P = .047, burst incidence P = .016); however, RHI (P = .24), AI (P = .201), ABPM (systolic P = .09, diastolic P = .14), and HRV were unaffected. Salt supplementation improved baroreflex (slope P = .026) and lowered aldosterone (P = .004), and in salt-resistant individuals there was a trend toward improved RHI (P = .07). CONCLUSIONS: In people with T2D and low habitual sodium intake, salt supplementation increased SNS activity without altering endothelial function or blood pressure but improved baroreflex function, a predictor of cardiac mortality. Salt-resistant individuals trended toward improved endothelial function with salt supplementation.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Baqar S, Kong YW, Chen AX, et al. Effect of Salt Supplementation on Sympathetic Activity and Endothelial Function in Salt-Sensitive Type 2 Diabetes. J Clin Endocrinol Metab. 2020. PMID: 31761946. doi:10.1210/clinem/dgz219

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。